Glowing dye could help surgeons spot hidden cancers during surgery
NCT ID NCT07124351
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a dye called pafolacianine (CYTALUX™) can make cancer cells glow under near-infrared light during surgery. Fifteen adults with gastric, esophageal, or appendiceal cancer will receive the dye before standard surgery. Surgeons will use a special camera to look for glowing tumors that might otherwise be missed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pafolacianine (CYTALUX™)
- What this could lead to
- If successful, this could help surgeons find and remove more cancer during surgery, potentially improving outcomes for people with these gastrointestinal cancers.
- What could go wrong
- This is a small, early feasibility study with only 15 participants, so results may not apply to everyone. The dye may not reliably highlight all cancer tissue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APPENDICEAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cedars-Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Can switching cancer therapy early extend life in stomach cancer?
- Blood test score may flag High-Risk esophageal surgery patients